Clinica Baviera SA (CBAV.MC) stock: key figures, P/E, revenue and dividend

Health Care · Spain · ISIN ES0119037010

Price
52.80 EUR
Market cap
845.53 m EUR
P/E (2025)
22.61
P/S (2025)
2.81
Dividend yield
2.97 %
Net margin
13.95 %
Return on equity (ROE)
38.19 %
Return on assets (ROA)
16.97 %

Clinica Baviera SA financials

Fiscal year20242025
Revenue262.00 m EUR301.00 m EUR
Gross profit232.00 m EUR127.00 m EUR
Operating income55.65 m EUR60.64 m EUR
EBIT57.00 m EUR82.00 m EUR
Net income40.00 m EUR42.00 m EUR
Diluted EPS – continuing operations2.51 EUR2.34 EUR

Full history since 2005, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Clinica Baviera SA

Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is based in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.